Dr. Hartung's clinical and translational research program focuses on autosomal recessive polycystic kidney disease and other genetic kidney diseases, development of new kidney and liver imaging biomarkers, and neurocognitive outcomes in children with chronic kidney disease.
Dr. Amaral's research is focused on kidney transplantation with particular interests in reducing treatment burden for adolescents and young adults — from designing studies to make daily medication regimens easier to diagnosing transplant injury earlier using innovative, noninvasive approaches.
Dr. Laskin's research focuses on the conduct of clinical investigations and translational studies designed to target mechanisms to prevent, treat, or slow the progression of chronic kidney disease in immunosuppressed patients, including children receiving a bone marrow or kidney transplant.
Dr. Levy-Erez's research is focused on the discovery of immune urinary biomarkers among children developing acute kidney injury. She is studying both a unique population of immune-compromised children after hematopoietic stem cell transplantation (HSCT) as well as children who have an intact immune system who develop acute kidney injury after cardiac bypass surgery.
Dr Jessica Wen is director of the Viral Hepatitis Treatment Program and a pediatric gastroenterologist at Children's Hospital of Philadelphia. She also works with CHOP's Liver Transplant Program and the Biesecker Pediatric Liver Center. Her research focuses on hepatitis B and C, and liver fibrosis.
Dr. Viteri is a pediatric nephrologist with an interest in renal imaging biomarkers, and works to develop renal imaging modalities to improve diagnostic tools and develop predictive models utilizing quantitative imaging analysis.